Calcium-binding proteins in skeletal muscles of the mdx mice: Potential role in the pathogenesis of Duchenne muscular dystrophy

International Journal of Experimental Pathology

Volumn 91, Issue 1, 2010, Pages 63-71

  Pertille, Adriana ^a   De Carvalho, Candida Luiza Tonizza ^a   Matsumura, Cintia Yuri ^a   Neto, Humberto Santo ^a   Marques, Maria Julia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Calmodulin; Calsequestrin; Cardiac muscle; Duchenne muscular dystrophy; Extraocular muscles; Mdx; Myonecrosis

Indexed keywords

BINDING PROTEIN; CALMODULIN; CALSEQUESTRIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BINDING; CALCIUM SIGNALING; CONTROLLED STUDY; DIAPHRAGM; DUCHENNE MUSCULAR DYSTROPHY; EXTRAOCULAR MUSCLE; HEART MUSCLE; IMMUNOBLOTTING; MALE; MOUSE; MUSCLE NECROSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SKELETAL MUSCLE; SOLEUS MUSCLE; STERNOCLEIDOMASTOID MUSCLE; TIBIALIS ANTERIOR MUSCLE;

ANIMALS; BLOTTING, WESTERN; CALMODULIN; CALSEQUESTRIN; DIAPHRAGM; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; MALE; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIUM; NECROSIS; PHENOTYPE;

EID: 74549123310     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2009.00688.x     Document Type: Article

References (46)

1. Alderton J.M. Steinhardt R.A. (2000) Calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. J. Biol. Chem. 275, 9452 9460.
2. 2+- calmodulin binds to the carboxyl-terminal domain of dystrophin. J. Biol. Chem. 271, 6605 6610.
3. Andrade F.H., Porter J.D., Kaminski H.J. (2000) Eye muscle sparing by the muscular dystrophies: lessons to be learned? Micros. Res. Tec. 48, 192 203.
4. Angus L.M., Chakkalakal J.V., Mejat A. et al. (2005) Calcineurin/NFAT signaling, together with GABP and PGC-1alpha, drives utrophin gene expression at the neuromuscular junction. Am. J. Physiol. Cell Physiol. 289, C908 C917.
5. Beard N.A., Laver D.R., Dulhunty A.F. (2004) Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog. Biophys. Mol. Biol. 85, 33 69.
6. Bostick B., Yue Y., Long C., Duan D. (2008) Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ. Res. 102, 121 130.
7. Bulfield G., Siller W.G., Wigth P.A.L., Moore K.J.X. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl Acad. Sci. USA 81, 1189 1192. (Pubitemid 14171480)
8. 2+/calmodulin signaling exacerbates the dystrophic phenotype in mdx mouse muscle. Hum. Mol. Genet. 15, 1423 1435.
9. Chin D. Means A.R. (2000) Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 10, 322 328.
10. Culligan K., Banville N., Dowling P., Ohlendieck K. (2002) Drastic reduction of calsequestrin-like proteins and impaired calcium binding in dystrophic mdx muscle. J. Appl. Physiol. 92, 435 445.
11. 2+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. Eur. J. Biochem. 271, 3943 3952.
12. Doran P., Dowling P., Donoghue P., Buffini M., Ohlendieck K. (2006) Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochem. Biophys. Acta 1764, 773 785.
13. Dowling P., Lohan J., Ohlendieck K. (2003) Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of β-dystroglycan. Eur. J. Cell Biol. 82, 222 230.
14. Dowling P., Doran P., Ohlendieck K. (2004) Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa) - deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. Biochem. J. 379, 479 488.
15. Engel A.G., Yamamoto M., Fischbeck K.H. (1994) Muscular dystrophies. In : Myology, pp. 1133 1187 (eds A.G. Engel C. Franzini-Armstrong New York : McGraw-Hill.
16. Ervasti J.M. (2007) Dystrophin, its interaction with other proteins, and implications for muscular dytrophy. Biochem. Biophys. Acta 1772, 108 117.
17. Ferretti R., Marques M.J., Pertille A., Santo Neto H. (2009) Sarcoplasmic-endoplasmic-reticulum ca(2+)-atpase and calsequestrin are overexpressed in spared intrinsic laryngeal muscles of dystrophin-deficient mdx mice. Muscle Nerve 39, 609 615.
18. Gailly P. (2002) New aspects of calcium signaling in skeletal muscle cells: Implications in Duchenne muscular dystrophy. Biochem. Biophys. Acta 1600, 38 44.
19. Grounds M.D., Radley H.G., Lynch G.S., Nagaraju K., De Luca A. (2008) Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol. Dis. 31, 1 19.
20. Haslett J.N., Kang P.B., Han M. et al. (2005) The influence of muscle type and dystrophin deficiency on murine expression profiles. Mamm. Genome 16, 739 748.
21. Hoffman E.P., Brown Jr. R.H., Kunkel L.M. (1987) Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919 928.
22. Khurana T.S., Watkins S.C., Chafey P. et al. (1991) Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul. Disord. 1, 185 194.
23. Khurana T.S., Predergast R.A., Alameddine H.S. et al. (1995) Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J. Exp. Med. 182, 467 474.
24. Lyons P.R. Slater C.R. (1991) Structure and function of the neuromuscular junction in young adult mdx mice. J. Neurocytol. 20, 969 981.
25. Marques M.J., Ferretti R., Vomero V.U., Minatel E., Santo Neto H. (2007a) Intrinsic laryngeal muscles are spared from myonecrosis in the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 35, 349 353.
26. Marques M.J., Pertille A., Carvalho C.L.T., Santo Neto H. (2007b) Acetylcholine receptor organization at the dystrophic extraocular muscle neuromuscular junction. Anat. Rec. 290, 846 854.
27. Matsumura K., Ervasti J.M., Ohlendieck K., Kahl S.D., Campbell K.P. (1992) Association of dystrophin-related protein with dystrophin associated proteins in mdx mouse muscle. Nature 360, 588 591.
28. Matsumura C.Y., Albuquerque T.C.P., Pertille A., Santo Neto H., Marques M.J. (2009) Diltiazem and verapamil protect dystrophin-deficient muscle fibers of mdx mice from degeneration: a potential role in calcium buffering and sarcolemmal stability. Muscle Nerve 39, 167 176.
29. McArdle A., Edwards R.H., Jackson M.J. (1994) Time course of changes in plasma membrane permeability in the dystrophin-deficient mdx mouse. Muscle Nerve 17, 1378 1384.
30. Petrof B.J., Shrager J.B., Stedman H.H., Kelly A.M., Sweeney H.L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA 90, 3710 3714.
31. Porter J.D. Baker R.S. (1996) Muscles of a different color: the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease. Neurology 46, 30 37.
32. Porter J.D., Baker R.S., Ragusa R.J., Brueckner J.K. (1995) Extraocular muscles: basic and clinical aspects of structure and function. Surv. Ophthalmol. 39, 451 484.
33. Porter J.D., Rafael J.A., Ragusa R.J., Brueckner J.K., Trickett J.I., Davies K.E. (1998) The sparing of extraocular muscle is lost in mice lacking utrophin and dystrophin. J. Cell Sci. 111, 1801 1811.
34. Quinlan J.G., Hahn H.S., Wong B.L., Lorenz J.N., Wenisch A.S., Levin L.S. (2004) Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul. Disor. 14, 491 496.
35. Rando T.A. (2001) The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 24, 1575 1594.
36. Rossi A.E. Dirksen R.T. (2006) Sarcoplasmic reticulum: the dynamic calcium governor of muscle. Muscle Nerve 33, 715 731.
37. Sicinski Y.G., Ryder-Cook A.S., Barnard E.A., Darlison M.G., Barnard P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 244, 1578 1580.
38. Spurney C.F., Knoblach S., Pistilli E.E., Nagaraju K., Martin G.R., Hoffman E.P. (2008) Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart. Neuromuscul. Disor. 18, 371 381.
39. Stedman H.H., Sweeney H.L., Shrager J.B. et al. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352, 536 539.
40. Stupka N., Michell B.J., Kemp B.E., Lynch G.S. (2006) Differential calcineurin signaling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mice. Neuromuscul. Disor. 16, 337 346.
41. Tidball J.G. Spencer M.J. (2000) Calpains and muscular dystrophies. Int. J. Biochem. Cell Biol. 32, 1 5.
42. Torres L.F. Duchen L.W. (1987) The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscle and end-plates. Brain 110, 269 299.
43. Turk R., Sterrenburg E., de Meijer E.J., van Ommen G.-J.B., den Dunnen J.T., Hoen P.A.C. (2005) Muscle regeneration in dystrophin-deficient mdx mice studied by gene expression profiling. BMC Genomics 6, 98 112.
44. Vandebrouck A., Sabourin J., Rivet J. et al. (2007) Regulation of capacitative calcium entries by α1-syntrophin:association of TRPC1 with dystrophin complex and the PDZ domain of α1-syntrophin. FASEB J. 21, 608 617.
45. Voisin V., Sébrié C., Matecki S. et al. (2005) L-arginine improves dystrophic phenotype in mdx mice. Neurobiol. Dis. 20, 123 130.
46. Whitehead N.P., Yeung E.W., Allen D.G. (2006) Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin. Exp. Pharmacol. Physiol. 33, 657 662.